CRISPR Therapeutics AG (CRSP) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of CRISPR Therapeutics AG and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRSP vs OSCR

growth of $100 · dividends reinvested · last 6y
CRSP -53.4% (-12.0%/yr)OSCR -14.1% (-2.5%/yr)OSCR compounded faster over this window
050100Start $10020222023202420252026$47$86
CRSP OSCR

CRSP vs OSCR: by the numbers

  • •OSCR is the larger company ($8.02B vs $5.35B market cap).
  • •OSCR is profitable (3.60% net margin) while CRSP runs a net loss (-3368.72%).
  • •OSCR grew revenue faster over the past five years (64.83% vs 37.32% CAGR).

Metrics side by side

Valuation

MetricCRSPOSCR
P/E ratioN/A22.10
Forward P/EN/A16.21
P/S ratio399.210.52
P/B ratio3.063.91
EV / EBITDAN/A6.71
FCF yieldN/A54.04%

Profitability

MetricCRSPOSCR
Gross margin-6537.01%14.38%
Operating margin-16191.40%4.07%
Net margin-3368.72%3.60%
ROE-25.83%26.84%
ROIC-21.12%22.98%

Growth (annualized)

MetricCRSPOSCR
Revenue CAGR (5Y)37.32%64.83%
FCF CAGR (5Y)N/A80.81%
Total return CAGR (5Y)-13.01%11.12%

Frequently asked

Which has grown faster, CRSP or OSCR?
Over the past five years, OSCR grew revenue faster — CRSP at a 37.32% CAGR versus OSCR at 64.83%.
Is CRSP or OSCR more profitable?
OSCR runs the higher net margin — CRSP at -3368.72% versus OSCR at 3.60%.
How have CRSP and OSCR total returns compared?
Over the past 5 years, CRSP delivered -13.01% and OSCR delivered 11.12% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.